129 related articles for article (PubMed ID: 23727574)
1. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2.
Yang T; Zhang GF; Chen XF; Gu HH; Fu SZ; Xu HF; Feng Q; Ni YM
Biochem Biophys Res Commun; 2013 Jul; 436(4):578-84. PubMed ID: 23727574
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
3. Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivo.
Yang T; Gu H; Chen X; Fu S; Wang C; Xu H; Feng Q; Ni Y
J Surg Res; 2014 Dec; 192(2):317-25. PubMed ID: 25085702
[TBL] [Abstract][Full Text] [Related]
4. FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Exp Cell Res; 2020 Aug; 393(1):112059. PubMed ID: 32380038
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of the Polycomb-Associated Methyltransferase Ezh2 during Maturation of Hippocampal Neurons Is Mediated by MicroRNAs Let-7 and miR-124.
Guajardo L; Aguilar R; Bustos FJ; Nardocci G; Gutiérrez RA; van Zundert B; Montecino M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187138
[TBL] [Abstract][Full Text] [Related]
6. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
8. The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart.
Mathiyalagan P; Okabe J; Chang L; Su Y; Du XJ; El-Osta A
Nucleic Acids Res; 2014 Jan; 42(2):790-803. PubMed ID: 24137001
[TBL] [Abstract][Full Text] [Related]
9. NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
Li Q; Lin X; Yang X; Chang J
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1340-7. PubMed ID: 20173049
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
[TBL] [Abstract][Full Text] [Related]
11. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.
Zhu WS; Tang CM; Xiao Z; Zhu JN; Lin QX; Fu YH; Hu ZQ; Zhang Z; Yang M; Zheng XL; Wu SL; Shan ZX
Oncotarget; 2016 Nov; 7(48):78331-78342. PubMed ID: 27823969
[TBL] [Abstract][Full Text] [Related]
12. PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
Chiang CW; Huang Y; Leong KW; Chen LC; Chen HC; Chen SJ; Chou CK
J Biomed Sci; 2010 May; 17(1):35. PubMed ID: 20444294
[TBL] [Abstract][Full Text] [Related]
13. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
14. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer.
Wu Q; Chen Z; Zhang G; Zhou W; Peng Y; Liu R; Chen C; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):693-700. PubMed ID: 29790898
[TBL] [Abstract][Full Text] [Related]
15. [Screening of novel miRNAs targeting EZH2 3' untranslated region using lentivirus miRNAs library and their expressions in breast cancer cells and tissues].
Liu C; Wang L; Zhao W; Peng Y; Wang Y; Sun Z; Feng J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):368-72. PubMed ID: 24670451
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of pharmacological EZH2 inhibition on malignant peripheral nerve sheath tumor through the miR-30a and KPNB1 pathway.
Zhang P; Yang X; Ma X; Ingram DR; Lazar AJ; Torres KE; Pollock RE
Mol Cancer; 2015 Mar; 14():55. PubMed ID: 25890085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]